I have been informed that Merck has appealed against the order denying interim injunction against Glenmark's drug "Zita", which allegedly infringes Merck's patented drug Sitagliptin (IN209816). The appeal, F.A.O.(O.S.) 190/2013, was listed before a Division Bench of the Delhi High Court presided by Justice Sanjay Kishan Kaul. We will keep our readers informed of the developments in the appeal.
No comments:
Post a Comment